Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Biosite Charts. Click Here for more Biosite Charts.](/p.php?pid=staticchart&s=N%5EBSTE&p=8&t=15)
Biosite(R) Incorporated Reports New Option Grants Under NASDAQ
Market Rule 4350
SAN DIEGO, June 21 /PRNewswire-FirstCall/ -- Biosite Incorporated
(NASDAQ:BSTE), today announced that, in accordance with NASDAQ Marketplace Rule
4350, 23 non-officer employees were granted inducement stock options covering
an aggregate of 23,900 shares of common stock. These options were granted
pursuant to NASDAQ Marketplace Rule 4350 (i)(1)(A)(iv) with the following
terms: each option has been classified as a non-qualified stock option, has an
exercise price equal to the fair market value on the grant date, has a ten-year
term, and vests in 16 equal quarterly installments over four years (on each
quarterly anniversary of the applicable vesting commencement date).
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The Company's
products contribute to improvements in medical care by aiding physicians in the
diagnosis of critical diseases and health conditions. Biosite's Triage(R) rapid
diagnostics are used in approximately 50 percent of U.S. hospitals and in over
50 international markets. Information on Biosite can be found at
http://www.biosite.com/.
Biosite(R) Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
DATASOURCE: Biosite Incorporated
CONTACT: Nadine Padilla, Vice President, Corporate & Investor Relations
of Biosite Incorporated, +1-858-455-4808, ext. 3187,
Web site: http://www.biosite.com/
Company News On-Call: http://www.prnewswire.com/comp/116737.html